Resalis Therapeutics SRL
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $22M
Investors
- 4
About Resalis Therapeutics SRL
Based in Turin, Italy, and founded in 2021, Resalis Therapeutics SRL operates as a biotechnology company that develops RES-010, a non-coding RNA (ncRNA)-based therapeutic solution for metabolic illnesses. Resalis Therapeutics SRL develops RES-010, an antisense oligonucleotide (ASO) and convenient treatment providing disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis, as well as targeting miR-22, a central player in regulating lipid metabolism and energy consumption. RES-010 provides a long-lasting therapeutic effect, alone or in combination with approved drugs. The company addresses two indications, obesity and fatty liver disease, with a high need for disease-modifying drugs that provide sustained clinical benefit.
Who invested in Resalis Therapeutics SRL
4 investors across 2 rounds
See all investors in Resalis Therapeutics SRL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Resalis Therapeutics SRL
Who invested in Resalis Therapeutics SRL?
Resalis Therapeutics SRL has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Resalis Therapeutics SRL raised?
Resalis Therapeutics SRL has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Resalis Therapeutics SRL last raise money?
Resalis Therapeutics SRL's most recent round on record is a Series A, in Jan 2024.
What does Resalis Therapeutics SRL do?
Based in Turin, Italy, and founded in 2021, Resalis Therapeutics SRL operates as a biotechnology company that develops RES-010, a non-coding RNA (ncRNA)-based therapeutic solution for metabolic illnesses.
Where is Resalis Therapeutics SRL headquartered?
Resalis Therapeutics SRL is headquartered in Turin, Italy.
Which VCs invest in companies like Resalis Therapeutics SRL?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Resalis Therapeutics SRL's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Resalis Therapeutics SRL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.